Oncostatin M Stimulates the Expression and Release of the IL-6 Receptor in Human Hepatoma HepG2 Cells

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5648-5653

  Cichy, Joanna ^a   Rose John, Stefan ^b   Potempa, Jan ^a   Pryjma, Juliusz ^a   Travis, James ^c  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c University of Georgia ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 1,10-PHENANTHROLINE; ANTINEOPLASTIC AGENT; DEXAMETHASONE; GROWTH INHIBITOR; INTERLEUKIN 6 RECEPTOR; ONCOSTATIN M; OSM PROTEIN, HUMAN; PEPTIDE; PHENANTHROLINE DERIVATIVE;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL CULTURE; DOSE RESPONSE; GENETIC TRANSFECTION; HUMAN; LIVER CELL CARCINOMA; METABOLISM;

ALTERNATIVE SPLICING; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH INHIBITORS; HUMANS; ONCOSTATIN M; PEPTIDES; PHENANTHROLINES; RECEPTORS, INTERLEUKIN-6; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031303474     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Baumann, H., and J. Gauldie. 1994. The acute phase response. Immunol. Today 15:74.
2. Garman, R. D., K. A. Jacobs, S. C. Clark, and D. H. Ravlet. 1987. B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc. Natl. Acad. Sci. USA 84:7629.
3. Taga, T., Y. Kawanishi, R. R. Hardy, T. Hirano, and T. Kishimoto. 1987. Receptors for B cell stimulatory factor 2: quantitation, specificity, distribution, and regulation of their expression. J. Exp. Med. 166:967.
4. Novic, D., H. Engelmann, D. Wallach, and M. Rubinstein. 1989. Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170:1409.
5. Honda, M., S. Yamamoto, M. Cheng, K. Yasukawa, H. Suzuki, T. Saito, Y. Osugi, T. Tokunaga, and T. Kishimoto. 1992. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immunol. 148:2175.
6. Peters, M., S. Jacobs, P. Vollmer, J. Mullberg, M. Ehlers, E. Wolf, G. Brem, K. H. Meyer zum Buschenfelde, and S. Rose-John. 1996. The function of the soluble IL-6 receptor: human soluble IL-6 receptor transgenic mice are hypersensitized towards the IL-6-mediated acute phase response and show prolonged plasma half life of IL-6. J. Exp. Med. 183:1399.
7. Peters, M., P. Schirmacher, J. Goldschmitt, M. Odenthal, C. Peschel, H. P. Dienes, E. Fattori, G. Ciliberto, H. K. Meyer zum Buschenfelde, and S. Rose-John. 1997. Extramedullary expansion of hematopoietic progenitor cells in IL-6/sIL-6R double transgenic mice. J. Exp. Med. 185:755.
8. Tamura, T., N. Udagawa, N. Takahashi, C. Miyaura, S. Tanaka, Y. Yamada, Y. Koishihara, Y. Ohsugi, K. Kumaki, and T. Taga. 1993. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc. Natl. Acad. Sci. USA 90:11924.
9. Udagawa, N., N. Takahashi, T. Katagiri, T. Tamura, S. Wada, D. M. Findlay, T. J. Martin, H. Hirota, T. Taga, T. Kishimoto, and T. Suda. 1995. Interleukin-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J. Exp. Med. 182:1461.
10. Yoshida, M., J. Sakuma, S. Hayashi, K. Abe, I. Saito, S. Harada, M. Sakatani, S. Yamamoto, N. Matsumoto, Y. Kaneda, and T. Kishimoto. 1995. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin-6, transforming growth factor β1, or platelet-derived growth factor B gene. Proc. Natl. Acad. Sci. USA 92:9570.
11. Cichy, J., S. Rose-John, J. Pryjma, and J. Travis. 1996. Effect of interleukin-6 receptor on interleukin-6 synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun. 227:318.
12. Pulkki, K., T. Pelliniemi, A. Rajamaki, A. Tienhaara, M. Laakso, and L. Lahtinen. 1996. Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Br. J. Haematol. 92:370.
13. Ohtani, K., H. Ninomiya, Y. Hasegawa, T. Kobayashi, H. Kojima, T. Nagasawa, and T. Abe. 1995. Clinical significance of elevated soluble interleukin-6 receptor levels in the sera of patients with plasma cell dyscrasias. Br. J. Haematol. 91:116.
14. Lavabre-Bertrand, T., C. Exbrayat, J. Liautard, J. P. Gaillard, P. P. Baskevitch, N. Poujol, C. Duperray, P. Bourquard, and J. Brochier. 1995. Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies. Br. J. Haematol. 91:871.
15. Rose-John, S., and P. C. Heinrich. 1994. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300:281.
16. Schooltink, H., T. Stoyan, D. Lenz, H. Schmitz, T. Hirano, T. Kishimoto, P. C. Heinrich, and S. Rose-John. 1991. Structural and functional studies on the human hepatic IL-6-receptor: molecular cloning and overexpression in HepG2 cells. Biochem. J. 277:659.
17. Van Dam, M., J. Mulberg, H. Schooltink, T. Stoyan, J. Brakenhoff, P. C. Heinrich, and S. Rose-John. 1993. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules: involvement of two separate domains in receptor binding. J. Biol. Chem. 268:15285.
18. Rose-John, S., A. Dietrich, and F. Marks. 1988. Molecular cloning of mouse protein kinase C (PKC) cDNA from Swiss 3T3 fibroblasts. Gene 74:465.
19. Scherrer, K., and Darnell, J. E. 1962. Sedimentation characteristic of rapidly labelled RNA from HeLa cells. Biochem. Biophys. Res. Commun. 7:486.
20. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratories, Cold Spring Harbor, NY.
21. Horiuchi, S., Y. Koyanagi, Y. Zhou, H. Miyamoto, Y. Tanaka, M. Waki, A. Matsumoto, M. Yamamoto, and N. Yamamoto. 1994. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur. J. Immunol. 24:1945.
22. Rose-John, S., H. Schooltink, D. Lenz, E. Hipp, G. Dufhues, H. Schmitz, X. Schiel, T. Hirano, T. Kishimoto, and P. C. Heinrich. 1990. Studies on the structure and regulation of the human hepatic interleukin-6-receptor. Eur. J. Biochem. 190:79.
23. Geisterfer, M., C. D. Richards, and J. Gauldie. 1995. Cytokines oncostatin M and interleukin-1 regulate the expression of the IL-6 receptor (gp80, gp130). Cytokine 7:503.
24. Mullberg, J., H. Schooltink, T. Stoyan, P. C. Heinrich, and S. Rose-John. 1992. Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor. Biochem. Biophys. Res. Commun. 189:794.
25. Mullberg, J., F. H. Durie, C. Otten-Evans, M. R. Alderson, S. Rose-John, D. Cosman, R. A. Black, and K. M. Mohler. 1995. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J. Immunol. 155:5198.
26. Walev, I., P. Volmer, M. Palmer, S. Bhakdi, and S. Rose-John. 1996. Pore forming toxins trigger shedding of receptors for interleukin-6 and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 93:7882.
27. Mullberg, J., H. Schooltink, T. Stoyan, M. Gunther, L. Graeve, G. Buse, A. Mackiewicz, P. C. Heinrich, and S. Rose-John. 1993. The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23:473.
28. Vollmer, P., I. Walev, S. Rose-John and S. Bhakdi. 1996. Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor. Infect. Immun. 64:3646.
29. Brown, T. J., M. N. Lioubin, and H. Marquardt. 1987. Synergistic antiproliferative activity of transforming growth factor β1, interferon-γ and oncostatin M for human melanoma cells. J. Immunol. 139:2977.
30. Richards, C. D., T. J. Brown, M. Shoyab, H. Baumann, and J. Gauldie. 1992. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J. Immunol. 148:1731.
31. Cichy, J., J. Potempa, R. K. Chawla, and J. Travis. 1995. Regulation of α1-antichymotrypsin synthesis in cells of epithelial origin. FEBS Lett. 359:262.
32. Cichy, J., J. Potempa, R. K. Chawla, and J. Travis. 1995. Stimulatory role of inflammatory cytokines on α1-antichymotrypsin expression in human lung-derived epithelial cells. J. Clin. Invest. 95:2729.
33. Cichy, J., J. Potempa, and J. Travis. 1997. Biosynthesis of α1-proteinase inhibitor by human lung-derived epithelial cells. J. Biol. Chem. 272:8250.
34. Brown, T. J., J. M. Rowe, and M. Shoyab. 1991. Regulation of interleukin-6 expression by oncostatin M. J. Immunol. 147:2175.
35. Yoshimura, A., M. Ichihara, I. Kinjyo, M. Moriyama, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, T. Hara, and A. Miyajima. 1996. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J. 15:1055.
36. Lust, J. A., K. A. Donovan, M. P. Kline, P. R. Greipp, R. A. Kyle, and N. J. Maihle. 1992. Isolation of mRNA encoding a soluble form of human interleukin-6 receptor. Cytokine 4:96.
37. Muller-Newen, G., C. Kohne, R. Keul, U. Hemmann, W. Muller-Esterl, J. Wijdenes, J. P. Brakenhoff, M. H. L. Hart, and P. C. Heinrich. 1996. Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. Eur. J. Biochem. 236:837.